pharmaphorum

Alphabet's Isomorphic raises $600m for AI drug discovery

Isomorphic Labs has raised a whopping $600 million to refine its artificial intelligence-powered drug discovery engine, advance its pipeline, and expand its headcount in its first external funding ...

Alphabet: Something Doesn't Add Up

Discover why Alphabet Inc.'s AI-driven growth and new revenue streams could mean its shares remain undervalued. Click for ...

Alphabet Has Everything Meta, Microsoft, And OpenAI Lack

Alphabet is emerging as the true ChatGPT Killer by embedding Gemini directly into the daily workflow of billions of users.
BioSpace

Novartis-Backed Protego Eyes Pivotal Amyloidosis Study With $130M Series B

Protego Biopharma is advancing a small-molecule drug that helps light chain proteins fold correctly, in turn addressing the ...

AI Drug Discovery Startup Iambic Raises $100M Following Encouraging Cancer Drug Data

Iambic, a clinical-stage life science and technology company that uses artificial intelligence to develop medicines has ...

2 Best AI Stocks to Buy This Month

Rachel Warren has positions in Alphabet and Amazon. The Motley Fool has positions in and recommends Alphabet, Amazon, GitLab, Microsoft, and Snowflake. The Motley Fool recommends the following options ...

Five years on, Google DeepMind’s AlphaFold shows why science may be AI’s killer app

In five years since AlphaFold's debut, it has transformed basic biochemical research. But its long-term effect on drug discovery remains unclear.
scmp.com

Hong Kong start-up IntelliGen AI aims to challenge Google DeepMind in drug discovery

In an interview with the Post, founder and president Ronald Sun expressed confidence that IntelliGen AI could soon compete globally with Isomorphic Labs, a spin-off of DeepMind, in leveraging AI for ...
Gizmodo

An AI That Promises to ‘Solve All Diseases’ Is About to Test Its First Human Drugs

A secretive, Google-backed lab is using artificial intelligence to invent new medicines for humanity's worst illnesses. But can we trust drugs designed by a mind that isn't human? Reading time 3 ...
Your Story

Google’s AI-designed drugs to enter human trials this year

Alphabet’s Isomorphic Labs is preparing to begin the first human clinical trials of a drug designed with the help of artificial intelligence, according to company leadership. The UK-based firm, which ...
NDTV

Google Ready To Start Human Trials Of Its AI-Designed Drugs

Google DeepMind's drug discovery company, Isomorphic Labs, is set to launch human trials of its AI-designed drugs. The company is aiming to use cutting-edge AI to design medicines faster, cheaper and ...
Hindustan Times

Isomorphic Labs’ AI designed drugs are about to hit human trials

Google DeepMind's spinoff Isomorphic Labs is set to begin human trials of a drug desinged completely by Artificial Intelligence. Isomorphic Labs, a drug discovery company spun out of Google DeepMind, ...